Fluorine in PDB 5yea: The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor
Enzymatic activity of The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor
All present enzymatic activity of The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor:
3.1.1.47;
Protein crystallography data
The structure of The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor, PDB code: 5yea
was solved by
Q.F.Liu,
Y.C.Xu,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
37.70 /
1.81
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
115.791,
83.408,
96.889,
90.00,
114.57,
90.00
|
R / Rfree (%)
|
17.7 /
21.1
|
Other elements in 5yea:
The structure of The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor
(pdb code 5yea). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor, PDB code: 5yea:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 5yea
Go back to
Fluorine Binding Sites List in 5yea
Fluorine binding site 1 out
of 6 in the The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F503
b:22.5
occ:1.00
|
F1
|
A:8U9503
|
0.0
|
22.5
|
1.0
|
C21
|
A:8U9503
|
1.3
|
19.6
|
1.0
|
F3
|
A:8U9503
|
2.1
|
21.4
|
1.0
|
F2
|
A:8U9503
|
2.1
|
23.8
|
1.0
|
C18
|
A:8U9503
|
2.4
|
20.1
|
1.0
|
C17
|
A:8U9503
|
3.0
|
21.3
|
1.0
|
CL1
|
A:8U9503
|
3.2
|
23.4
|
1.0
|
C19
|
A:8U9503
|
3.4
|
17.7
|
1.0
|
CE1
|
A:PHE357
|
3.6
|
18.0
|
1.0
|
CD1
|
A:PHE357
|
3.6
|
17.6
|
1.0
|
CD2
|
A:LEU121
|
4.1
|
22.6
|
1.0
|
C16
|
A:8U9503
|
4.3
|
19.4
|
1.0
|
CE2
|
A:PHE125
|
4.4
|
23.9
|
1.0
|
CZ
|
A:PHE357
|
4.4
|
16.9
|
1.0
|
CG
|
A:PHE357
|
4.5
|
16.9
|
1.0
|
CD1
|
A:LEU371
|
4.5
|
19.3
|
1.0
|
C14
|
A:8U9503
|
4.6
|
16.2
|
1.0
|
CZ
|
A:PHE125
|
4.9
|
24.9
|
1.0
|
CD1
|
A:LEU369
|
4.9
|
24.1
|
1.0
|
C15
|
A:8U9503
|
5.0
|
15.3
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 5yea
Go back to
Fluorine Binding Sites List in 5yea
Fluorine binding site 2 out
of 6 in the The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F503
b:23.8
occ:1.00
|
F2
|
A:8U9503
|
0.0
|
23.8
|
1.0
|
C21
|
A:8U9503
|
1.3
|
19.6
|
1.0
|
F1
|
A:8U9503
|
2.1
|
22.5
|
1.0
|
F3
|
A:8U9503
|
2.1
|
21.4
|
1.0
|
C18
|
A:8U9503
|
2.4
|
20.1
|
1.0
|
C17
|
A:8U9503
|
3.0
|
21.3
|
1.0
|
CL1
|
A:8U9503
|
3.0
|
23.4
|
1.0
|
CD1
|
A:LEU111
|
3.1
|
26.0
|
1.0
|
C19
|
A:8U9503
|
3.5
|
17.7
|
1.0
|
CD2
|
A:LEU121
|
3.6
|
22.6
|
1.0
|
CD1
|
A:LEU121
|
3.8
|
22.8
|
1.0
|
C16
|
A:8U9503
|
4.3
|
19.4
|
1.0
|
CG
|
A:LEU121
|
4.4
|
25.2
|
1.0
|
CG
|
A:LEU111
|
4.6
|
23.6
|
1.0
|
C14
|
A:8U9503
|
4.6
|
16.2
|
1.0
|
C15
|
A:8U9503
|
5.0
|
15.3
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 5yea
Go back to
Fluorine Binding Sites List in 5yea
Fluorine binding site 3 out
of 6 in the The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F503
b:21.4
occ:1.00
|
F3
|
A:8U9503
|
0.0
|
21.4
|
1.0
|
C21
|
A:8U9503
|
1.3
|
19.6
|
1.0
|
F1
|
A:8U9503
|
2.1
|
22.5
|
1.0
|
F2
|
A:8U9503
|
2.1
|
23.8
|
1.0
|
C18
|
A:8U9503
|
2.3
|
20.1
|
1.0
|
C19
|
A:8U9503
|
2.7
|
17.7
|
1.0
|
CE1
|
A:PHE357
|
3.2
|
18.0
|
1.0
|
CZ
|
A:PHE357
|
3.4
|
16.9
|
1.0
|
CD2
|
A:LEU121
|
3.6
|
22.6
|
1.0
|
C17
|
A:8U9503
|
3.6
|
21.3
|
1.0
|
CD1
|
A:LEU121
|
3.7
|
22.8
|
1.0
|
CD1
|
A:PHE357
|
3.9
|
17.6
|
1.0
|
C14
|
A:8U9503
|
4.1
|
16.2
|
1.0
|
CE2
|
A:PHE357
|
4.1
|
13.6
|
1.0
|
CG
|
A:LEU121
|
4.2
|
25.2
|
1.0
|
CL1
|
A:8U9503
|
4.4
|
23.4
|
1.0
|
CD1
|
A:LEU107
|
4.5
|
16.1
|
1.0
|
CG
|
A:PHE357
|
4.5
|
16.9
|
1.0
|
CD1
|
A:LEU111
|
4.5
|
26.0
|
1.0
|
CD2
|
A:PHE357
|
4.6
|
13.6
|
1.0
|
CE2
|
A:PHE125
|
4.7
|
23.9
|
1.0
|
C16
|
A:8U9503
|
4.8
|
19.4
|
1.0
|
CB
|
A:LEU121
|
4.8
|
20.8
|
1.0
|
O5
|
A:8U9503
|
4.9
|
17.1
|
1.0
|
CD2
|
A:PHE125
|
4.9
|
21.4
|
1.0
|
C15
|
A:8U9503
|
4.9
|
15.3
|
1.0
|
CB
|
A:LEU107
|
5.0
|
15.9
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 5yea
Go back to
Fluorine Binding Sites List in 5yea
Fluorine binding site 4 out
of 6 in the The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F502
b:26.5
occ:1.00
|
F1
|
B:8U9502
|
0.0
|
26.5
|
1.0
|
C21
|
B:8U9502
|
1.3
|
24.0
|
1.0
|
F3
|
B:8U9502
|
2.1
|
27.0
|
1.0
|
F2
|
B:8U9502
|
2.1
|
23.8
|
1.0
|
C18
|
B:8U9502
|
2.4
|
18.8
|
1.0
|
C17
|
B:8U9502
|
3.0
|
23.1
|
1.0
|
CL1
|
B:8U9502
|
3.2
|
28.2
|
1.0
|
C19
|
B:8U9502
|
3.4
|
22.3
|
1.0
|
CE1
|
B:PHE357
|
3.6
|
19.8
|
1.0
|
CD1
|
B:PHE357
|
3.7
|
15.6
|
1.0
|
CD2
|
B:LEU121
|
3.9
|
26.6
|
1.0
|
CE2
|
B:PHE125
|
4.3
|
27.1
|
1.0
|
C16
|
B:8U9502
|
4.3
|
20.8
|
1.0
|
CZ
|
B:PHE357
|
4.4
|
19.9
|
1.0
|
CD1
|
B:LEU371
|
4.4
|
25.4
|
1.0
|
CG
|
B:PHE357
|
4.5
|
20.1
|
1.0
|
C14
|
B:8U9502
|
4.6
|
16.5
|
1.0
|
CZ
|
B:PHE125
|
4.6
|
29.0
|
1.0
|
CD1
|
B:LEU369
|
5.0
|
31.9
|
1.0
|
C15
|
B:8U9502
|
5.0
|
19.2
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 5yea
Go back to
Fluorine Binding Sites List in 5yea
Fluorine binding site 5 out
of 6 in the The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F502
b:23.8
occ:1.00
|
F2
|
B:8U9502
|
0.0
|
23.8
|
1.0
|
C21
|
B:8U9502
|
1.3
|
24.0
|
1.0
|
F1
|
B:8U9502
|
2.1
|
26.5
|
1.0
|
F3
|
B:8U9502
|
2.1
|
27.0
|
1.0
|
C18
|
B:8U9502
|
2.4
|
18.8
|
1.0
|
C17
|
B:8U9502
|
3.0
|
23.1
|
1.0
|
CL1
|
B:8U9502
|
3.1
|
28.2
|
1.0
|
CD1
|
B:LEU111
|
3.1
|
26.5
|
1.0
|
CD2
|
B:LEU121
|
3.3
|
26.6
|
1.0
|
C19
|
B:8U9502
|
3.5
|
22.3
|
1.0
|
CD1
|
B:LEU121
|
3.8
|
27.0
|
1.0
|
CG
|
B:LEU121
|
4.2
|
26.3
|
1.0
|
C16
|
B:8U9502
|
4.3
|
20.8
|
1.0
|
CG
|
B:LEU111
|
4.6
|
25.9
|
1.0
|
C14
|
B:8U9502
|
4.6
|
16.5
|
1.0
|
C15
|
B:8U9502
|
5.0
|
19.2
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 5yea
Go back to
Fluorine Binding Sites List in 5yea
Fluorine binding site 6 out
of 6 in the The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of The Crystal Structure of Lp-PLA2 in Complex with A Novel Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F502
b:27.0
occ:1.00
|
F3
|
B:8U9502
|
0.0
|
27.0
|
1.0
|
C21
|
B:8U9502
|
1.3
|
24.0
|
1.0
|
F1
|
B:8U9502
|
2.1
|
26.5
|
1.0
|
F2
|
B:8U9502
|
2.1
|
23.8
|
1.0
|
C18
|
B:8U9502
|
2.3
|
18.8
|
1.0
|
C19
|
B:8U9502
|
2.7
|
22.3
|
1.0
|
CE1
|
B:PHE357
|
3.3
|
19.8
|
1.0
|
CZ
|
B:PHE357
|
3.3
|
19.9
|
1.0
|
CD2
|
B:LEU121
|
3.5
|
26.6
|
1.0
|
C17
|
B:8U9502
|
3.6
|
23.1
|
1.0
|
CD1
|
B:PHE357
|
3.9
|
15.6
|
1.0
|
CD1
|
B:LEU121
|
3.9
|
27.0
|
1.0
|
CE2
|
B:PHE357
|
4.0
|
18.8
|
1.0
|
C14
|
B:8U9502
|
4.0
|
16.5
|
1.0
|
CG
|
B:LEU121
|
4.2
|
26.3
|
1.0
|
CD1
|
B:LEU107
|
4.3
|
15.5
|
1.0
|
CL1
|
B:8U9502
|
4.4
|
28.2
|
1.0
|
CG
|
B:PHE357
|
4.5
|
20.1
|
1.0
|
CE2
|
B:PHE125
|
4.5
|
27.1
|
1.0
|
CD2
|
B:PHE357
|
4.6
|
17.7
|
1.0
|
CD1
|
B:LEU111
|
4.6
|
26.5
|
1.0
|
CB
|
B:LEU121
|
4.7
|
23.9
|
1.0
|
C16
|
B:8U9502
|
4.8
|
20.8
|
1.0
|
O5
|
B:8U9502
|
4.8
|
18.7
|
1.0
|
CD2
|
B:PHE125
|
4.8
|
25.4
|
1.0
|
C15
|
B:8U9502
|
4.9
|
19.2
|
1.0
|
CB
|
B:LEU107
|
4.9
|
16.6
|
1.0
|
|
Reference:
Q.Liu,
F.Huang,
X.Yuan,
K.Wang,
Y.Zou,
J.Shen,
Y.Xu.
Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2. J. Med. Chem. V. 60 10231 2017.
ISSN: ISSN 1520-4804
PubMed: 29193967
DOI: 10.1021/ACS.JMEDCHEM.7B01530
Page generated: Thu Aug 1 17:12:48 2024
|